NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis $1.01 0.00 (0.00%) (As of 12/24/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends About Global Cord Blood Stock (NYSE:CO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Global Cord Blood alerts:Sign Up Key Stats Today's Range$1.00▼$1.0150-Day Range$1.05▼$2.9952-Week Range$2.03▼$5.50Volume5,220 shsAverage Volume216,519 shsMarket Capitalization$122.77 millionP/E Ratio1.58Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGlobal Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More… Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Stock News HeadlinesAutologous cord-blood-derived cell administration in extremely preterm infantsDecember 16, 2024 | msn.comHazard NJ Traces ‘Forever Chemicals’ From NJ Roots To Global CrisisNovember 24, 2024 | myveronanj.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.December 25, 2024 | Crypto Swap Profits (Ad)U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy ProductNovember 22, 2024 | finance.yahoo.comExtra ingredient to be added to all bread in pregnancy health bidNovember 14, 2024 | msn.comCommon plastic chemical could threaten fertility of humans worldwideNovember 5, 2024 | msn.comWhat’s the Election About? What No One Can Bear to Talk About.November 2, 2024 | msn.comONWARD® Medical Publishes Closing of Bookbuild OfferingOctober 28, 2024 | markets.businessinsider.comSee More Headlines CO Stock Analysis - Frequently Asked Questions How have CO shares performed this year? Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CO stock has decreased by 17.2% and is now trading at $1.01. View the best growth stocks for 2024 here. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) announced its quarterly earnings data on Tuesday, June, 26th. The medical research company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company earned $37.14 million during the quarter. How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some other companies that Global Cord Blood investors own include Micron Technology (MU), Dynavax Technologies (DVAX), AT&T (T), Vale (VALE), Cisco Systems (CSCO), Pfizer (PFE) and United Microelectronics (UMC). Company Calendar Last Earnings6/26/2018Today12/25/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.58 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.10 Cash Flow$0.24 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.16Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$122.77 million OptionableNo Data Beta0.16 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:CO) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.